BTIG Downgrades Neogenomics (NEO) to Neutral
Tweet
Share
E-mailGet Alerts NEO Hot Sheet
Price: $16.16 +1.38%
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
BTIG analyst Mark Massaro downgraded Neogenomics (NASDAQ: NEO) from Buy to Neutral.
For an analyst ratings summary and ratings history on Neogenomics click here. For more ratings news on Neogenomics click here.
Shares of Neogenomics closed at $11.68 yesterday.
You May Also Be Interested In
- Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
- Cantor Fitzgerald Downgrades EyePoint Inc. (EYPT) to Neutral
- B.Riley Downgrades Lantheus Holdings (LNTH) to Neutral
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
